Europe Smoking Cessation and Nicotine De-Addiction Market, By Product Type (Nicotine Replacement Therepy Products, Drug Therepy, E-Cigarettes, and Others), Treatment Type (Pharmacological, Therapies, and Others), Form (Gum, Inhaler, Tablet, and Others), Distribution Channel (Online, and Offline), End-User (Generation Z, Millennials, Generation X and Silent Generation) – Industry Trends and Forecast to 2031.
Europe Smoking Cessation and Nicotine De-Addiction Market Analysis and Size
The smoking cessation and nicotine de-addiction market offers various applications, including pharmaceuticals, nicotine replacement therapies, and behavioral therapies, aiding individuals in quitting smoking. Innovations such as mobile apps for tracking progress and virtual support groups enhance efficacy. This market addresses the urgent need for effective solutions to combat nicotine addiction.
Data Bridge Market Research analyses that the Europe smoking cessation and nicotine de-addiction market was valued at USD 17.70 billion in 2023 and is expected to reach USD 107.57 billion by 2031, registering a CAGR of 25.3% during the forecast period of 2024-2031. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and consumer behaviour.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016- 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Nicotine Replacement Therepy Products, Drug Therepy, E-Cigarettes, and Others), Treatment Type (Pharmacological, Therapies, and Others), Form (Gum, Inhaler, Tablet, and Others), Distribution Channel (Online, and Offline), End-User (Generation Z, Millennials, Generation X and Silent Generation)
|
|
Countries Covered
|
Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe
|
|
Market Players Covered
|
Cipla Inc. (India), Johnson & Johnson Services, Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Alkalon A/S (Denmark), 22nd Century Group, Inc. (U.S.), GSK plc. (U.K.), Imperial Brands plc (U.K.), JT International SA (Japan), BAT (U.K.), Perrigo Company plc (Ireland), Fertin Pharma (Denmark), Cambrex Corporation (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Pfizer Inc. (U.S.), Strides Pharma Science Limited (India)
|
|
Market Opportunities
|
|
Market Definition
Smoking cessation and nicotine de-addiction involve interventions and strategies aimed at helping individuals quit smoking and overcome nicotine addiction. This encompasses medical aids, nicotine replacement therapies, behavioral counseling, and support programs. Effective cessation methods are crucial for improving public health and reducing the harmful effects of tobacco use.
Europe Smoking Cessation and Nicotine De-Addiction Market Dynamics
Drivers
- Rapidly Evolving Social Norms Towards Quitting
Changing societal views on smoking boost demand for cessation aid. Peer pressure and workplace policies advocating smoke-free spaces strengthen cessation attempts. Stigma linked to smoking further propels individuals towards quitting. This shift in norms fosters a surge in seeking support for smoking cessation, reflecting a broader cultural trend towards healthier lifestyles.
- Government Regulations for Smoking Cessation Products
Government regulations worldwide, such as tobacco taxes, advertising bans, and smoke-free policies, drive demand for smoking cessation products by incentivizing smokers to quit. These stringent policies create a conducive environment for individuals to seek cessation support, contributing to the growth of the smoking cessation and nicotine de-addiction market.
Opportunities
- Growing Holistic Cessation Programs for Nicotine Addiction
Understanding the psychological and behavioral dimensions of nicotine addiction drives the demand for holistic cessation programs. Counseling, support groups, and digital platforms provide personalized coaching and behavioral therapy, complementing pharmacological treatments. This integrated approach enhances long-term success rates in quitting smoking by addressing underlying psychological factors effectively.
- Growing Health Awareness Campaigns for Smoke-Free Life
Public health campaigns raise awareness of smoking's health risks such as cancer and heart disease, urging individuals to quit. Highlighting benefits of cessation, these initiatives encourage seeking treatments. Through educating on the dangers and advantages of quitting, they play a pivotal role in motivating smokers to take steps towards a smoke-free life, fostering healthier communities.
Restraints/Challenges
- Dual Use of Tobacco and Electronic Cigarettes
The dual use of electronic cigarettes alongside traditional cigarettes poses a challenge to the smoking cessation market. While some view e-cigarettes as a cessation aid, they can perpetuate nicotine addiction, hindering efforts to quit altogether. This behavior prolongs dependence on nicotine, reducing the demand for traditional cessation products and impacting the market's growth.
- High Relapse Rates in Smoking Cessation
The persistent issue of high relapse rates in smoking cessation presents a formidable obstacle for the market. Existing interventions fall short in delivering lasting outcomes, undermining consumer contentment and hindering the expansion and durability of the smoking cessation and nicotine de-addiction market.
This Europe smoking cessation and nicotine de-addiction market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe smoking cessation and nicotine de-addiction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In March 2021, Pfizer Inc. expanded its business by developing a supplemental New Drug Application for anaplastic lymphoma kinase treatment. This diversification could boost revenue and indirectly contribute to smoking cessation efforts by strengthening the company's overall financial position
- In March 2021, Takeda Pharmaceutical Company Limited acquired Maverick Therapeutics, enhancing its tumor therapy and T cell development portfolio. This strategic move support smoking cessation initiatives by bolstering Takeda's resources and potentially funding research in the field
- In February 2020, Strides Pharma Science Limited, via its subsidiary Strides Consumer Private Limited, entered the market with two over-the-counter products for smoking cessation and joint pain relief. This expansion aligns with addressing health concerns, potentially providing accessible solutions for individuals seeking to quit smoking
Europe Smoking Cessation and Nicotine De-Addiction Market Scope
The Europe smoking cessation and nicotine de-addiction market is segmented on the basis of product type, treatment type, form, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Nicotine Replacement Therepy Products
- Over-the-Counter
- Prescription
- Drug Therepy
- Varenicline
- Zyban
- E-Cigarettes
- Modular
- Disposable
- Rechargeable
- Others
- With Nicotine
- Without Nicotine
Treatment Type
- Pharmacological
- Therapies
- Others
Form
- Gum
- Inhaler
- Tablet
- Others
Distribution Channel
- Online
- Offline
- Hospital Pharmacies
- Drug stores
- Retail Pharmacies
End-User
- Generation Z
- Millennials
- Generation X
- Silent Generation
Europe Smoking Cessation and Nicotine De-Addiction Market Regional Analysis/Insights
The Europe smoking cessation and nicotine de-addiction market is analyzed and market size insights and trends are provided by product type, treatment type, form, distribution channel and end-user as referenced above.
The countries covered in the Europe smoking cessation and nicotine de-addiction market report are Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe.
The U.K. dominates the Europe smoking cessation and nicotine de-addiction market, leveraging high innovations and product development. This fosters a substantial customer base. The demand for nicotine-containing products is rising due to an increased preference for nicotine-free alternatives.
In Germany, the demand for nicotine-containing products is on the rise, driven by increased production alongside a growing preference for nicotine-free alternatives.
France experiences a growing demand for nicotine-containing products due to heightened awareness among the population, spurred by the rising incidence of smoking-related diseases.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Smoking Cessation and Nicotine De-Addiction Market Share Analysis
The Europe smoking cessation and nicotine de-addiction market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe smoking cessation and nicotine de-addiction market.
Some of the major players operating in the Europe smoking cessation and nicotine de-addiction market are:
- Cipla Inc. (India)
- Johnson & Johnson Services, Inc. (U.S.)
- Takeda Pharmaceutical Company Limited (Japan)
- Alkalon A/S (Denmark)
- 22nd Century Group, Inc. (U.S.)
- GSK plc. (U.K.)
- Imperial Brands plc (U.K.)
- JT International SA (Japan)
- BAT (U.K.)
- Perrigo Company plc (Ireland)
- Fertin Pharma (Denmark)
- Cambrex Corporation (U.S.)
- Dr. Reddy’s Laboratories Ltd. (India)
- Pfizer Inc. (U.S.)
- Strides Pharma Science Limited (India)
SKU-